Shanghai Baolong Pharmacy

Shanghai Baolong Pharmaceutical is a Chinese pharmaceutical company that specializes in the development and manufacturing of traditional Chinese medicines (TCM) and chemical drugs. Founded in 1993 and based in Shanghai, the company is widely recognized for its respiratory and pediatric product lines, most notably its Compound Licorice Tablets. In 2015, the company was acquired by Fosun Pharma, becoming a wholly-owned subsidiary and a key production base within the Fosun healthcare ecosystem. Baolong operates advanced GMP-certified facilities that produce a variety of formulations, including tablets, capsules, and granules. The company focuses on providing high-quality, affordable medications for common ailments in the domestic Chinese market.